Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 848

1.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

Fu KK, Cooper JS, Marcial VA, Laramore GE, Pajak TF, Jacobs J, Al-Sarraf M, Forastiere AA, Cox JD.

Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):425-38.

PMID:
8655364
2.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Review.

PMID:
17482300
3.

Hypoxic sensitizer and cytotoxin for head and neck cancer.

Lee DJ, Moini M, Giuliano J, Westra WH.

Ann Acad Med Singapore. 1996 May;25(3):397-404. Review.

PMID:
8876907
4.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
5.

Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL.

Head Neck. 2005 Oct;27(10):843-50.

PMID:
16161069
6.

Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.

Marcial VA, Pajak TF, Kramer S, Davis LW, Stetz J, Laramore GE, Jacobs JR, Al-Sarraf M, Brady LW.

Semin Oncol. 1988 Feb;15(1):39-60.

PMID:
3278390
7.

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):777-82.

PMID:
9128951
8.

Overview of combined modality therapies for head and neck cancer.

Dimery IW, Hong WK.

J Natl Cancer Inst. 1993 Jan 20;85(2):95-111. Review.

PMID:
8418313
9.

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia LR, Rotman M, Ortiz H.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1069-75.

PMID:
9869231
10.
11.
12.
13.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
14.

Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.

Krstevska V.

J BUON. 2009 Jul-Sep;14(3):361-73. Review.

PMID:
19810125
15.
16.
17.

Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.

Puc MM, Chrzanowski FA Jr, Tran HS, Liu L, Glicksman AS, Landman C, Slotman GJ.

Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):337-42.

PMID:
10722006
18.

Clinical trials of neutron radiotherapy in the United States.

Lindsley KL, Cho P, Stelzer KJ, Koh WJ, Austin-Seymour M, Russell KJ, Laramore GE, Griffin TW.

Bull Cancer Radiother. 1996;83 Suppl:78s-86s.

PMID:
8949756
19.
20.

Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer.

Rudat V, Wannenmacher M.

Semin Surg Oncol. 2001 Jan-Feb;20(1):66-74. Review.

PMID:
11291134
Items per page

Supplemental Content

Support Center